PETALING JAYA: A campaign has been launched for clear guidelines about vaccinations for expectant mothers as daily Covid-19 cases soar to an all-time high.
Liyana Helmy Had, who is pregnant with her second child, says there is still a lack of clarification about the vaccination process, with questions remaining over her chances in receiving the Pfizer vaccine, the only one recommended by the government for expecting and breastfeeding mothers.
She has launched a petition supported by more than 100 signatories, for more detailed guidelines.
“All we know is that we’re considered a high-risk group, and that the Pfizer vaccine is suitable for those between 14 to 33 weeks of pregnancy,” she told FMT.
However, she questioned how expectant women would be identified under the national immunisation programme as the MySejahtera application does not require applicants to declare if they were pregnant.
“The vaccination registration form does not include questions on pregnancy and nursing, so we are curious how the government is planning for the Pfizer stock to accommodate us,” she said.
According to the national immunisation campaign, women who are 14 to 33 weeks pregnant may receive the Pfizer vaccine or delay it until after delivery, while AstraZeneca and Sinovac vaccines are not recommended.
Now 12 weeks into her pregnancy, Liyana, 30, wondered if there was a sufficient amount of Pfizer vaccines available.
She said there had not been a response to the many comments and enquiries on the vaccine special committee’s social media channels.
Stating that the UK government has a very detailed list of frequently asked questions, she added: “It provides comprehensive guidelines for vulnerable groups, and it helps the people make informed decisions about taking the vaccine.”
Last month, an Oxford University study found that pregnant women infected with Covid-19 were more likely to face higher risks of complications.
Another British study suggested that having Covid-19 close to the time of birth increases the chances of stillbirths or premature babies, although the overall risks remain low.